Korean Immigrant Women's Meanings of Breast, Breast Cancer, and Breast Cancer Screenings

2006 ◽  
Vol 36 (4) ◽  
pp. 604 ◽  
Author(s):  
Eunyoung Eunice Suh
Keyword(s):  
Breast Cancer ◽  
Korean Immigrant ◽  
Cancer Screenings ◽  
Breast Breast Cancer

Management of breast cancer 50 years ago

2020 ◽  
Vol 81 (3) ◽  
pp. 1-2
Author(s):  
Harold Ellis
Keyword(s):  
Breast Cancer ◽  
Medical School ◽  
General Surgeon ◽  
Academic Unit ◽  
Breast Breast Cancer

In 1970, 50 years ago, I had headed the newly established Academic Unit of Surgery at the Westminster Medical School for 10 years. Since my appointment there in 1960, and for the next 30 years, one of my main interests as a general surgeon was the management of diseases of the breast – breast cancer in particular.

Factors and trends in cancer screening in the United States from 2004 to 2010.

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. 1565-1565
Author(s):  
Thanyanan Reungwetwattana ◽  
Julian R. Molina ◽  
Jeanette Y. Ziegenfuss
Keyword(s):  
Breast Cancer ◽  
Prostate Cancer ◽  
Cervical Cancer ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Cervical Cancer Screening ◽  
Prostate Cancer Screening ◽  
Cancer Screenings ◽  
The Us ◽  
Race Ethnicity

1565 Background: Understanding the prevalence of cancer screening in the US and the factors associated with its accessibility is important for public health promotion. Methods: The 2004 and 2010 Behavioral Risk Factor Surveillance Systems were used to ascertain cancer screening rates among populations indicated for each test by age, gender, and the American Cancer Society recommendation for cancer screenings [fecal occult blood test (FOBT) or endoscopy for colorectal cancer (CRC) screening, digital rectal examination (DRE) or prostate specific antigen (PSA) for prostate cancer screening, clinical breast examination (CBE) or mammogram for breast cancer screening, and Papanicolaou (Pap) test for cervical cancer screening]. Results: Over this period, CRC and breast cancer screening rates significantly increased (15.9%, 13.9%) while prostate and cervical cancer screening rates significantly decreased (1.2%, 5.2%). Race/ethnicity might be an influence in CRC and cervical cancer screening accessibility. Prostate cancer screening accessibility might be influenced by education and income. The older-aged populations (70-79, >79) had high prevalence of CRC, prostate and breast cancer screenings even though there is insufficient evidence for the benefits and harms of screenings in the older-aged group. Conclusions: The disparities in age, race/ethnicity, health insurance, education, employment, and income for the accession to cancer screening of the US population have decreased since 2004. The trajectory of increasing rates of CRC and breast cancer screenings should be maintained. To reverse the trend, the causes of the decreased rate of cervical cancer screening and the high rates of screenings in older-aged populations should, however, be further explored. [Table: see text]

scholarly journals Public Policies and patents for breast cancer in Brazil, India and Australia

2018 ◽  
Vol 6 (10) ◽  
pp. 287-298
Author(s):  
Áurea Machado de Aragão ◽  
Antônio Martins De Oliveira Júnior
Keyword(s):  
Public Health ◽  
Breast Cancer ◽  
Public Policies ◽  
Public Health Problem ◽  
Access To Medicines ◽  
Self Awareness ◽  
Cancer Breast ◽  
Incidence And Mortality ◽  
Breast Breast Cancer ◽  
Research Investments

This article illustrates that public policies to facilitate access to medicines, research investments, and self-awareness for breast cancer are the way to change the scenario of breast cancer in Brazil, India and Australia. The motivation was due to the fact that the literature reports breast cancer as a public health problem due to high incidence and mortality rates, whether the country is developed or not. The method adopted was the review study based on the data analysis on public policies and patents for breast cancer in Brazil, India and Australia available in official websites, INPI, Espacenet and Patentscope databases, journals and international newspapers Specialized and physical literature related to the theme. The descriptors used were cancer, breast, breast cancer, breast cancer and Australia, cancer patents, breast cancer and India. The following inclusion criteria used were year and period of publication, availability of the article in full and the intersection between the descriptors. The research concluded that there is an urgent need to prioritize public health with more investment in breast cancer research and awareness programs on the importance of early detection in those countries, primarily in India.

scholarly journals Food security status and breast cancer screening among women in the United States: Evidence from Health and Retirement Study and Health Care and Nutrition Study

2021 ◽  
Author(s):  
Asos Mahmood ◽  
Satish Kedia ◽  
Patrick Dillon ◽  
Hyunmin kim ◽  
Hassan Arshad ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Health Care ◽  
Cancer Screening ◽  
Food Insecurity ◽  
Breast Cancer Screening ◽  
The United States ◽  
The Past ◽  
Cancer Screenings ◽  
Nutrition Study ◽  
Retirement Study

Abstract Purpose: To assesses the impact of food insecurity on biennial breast cancer screenings (i.e., mammography or breast x-ray) among older women in the United States (US).Methods: Data from the 2014 and 2016 waves of the Health and Retirement Study and the 2013 Health Care and Nutrition Study were used. The analyses were limited to a nationally representative sample of 2,861 women between 50 to 74 years of age, residing in the US. We employed a propensity score weighting method to balance observed confounders between food-secure and food-insecure women and fitted a binary logistic regression to investigate population-level estimates for the association between food security and breast cancer screening.Results: Food insecurity was significantly associated with failure to obtain a mammogram or breast x-ray within the past two years. Food-insecure women had 54% lower odds of reporting breast cancer screening in the past two years (OR=0.46; 95% CI: 0.30-0.70, P-value <.001) as compared to food-secure women. Additional factors associated with a higher likelihood of receiving breast cancer screenings included greater educational attainment, higher household income, regular access to health care/advice, not smoking, and not being physically disabled or experiencing depressive symptoms.Conclusion: Results demonstrate a socioeconomic gradient existing in regard to the utilization of regular breast cancer screenings among women. Those who tend to have lower education, lower-income and lack of reliable healthcare access are more likely to be food insecure. Thus, more likely to face the financial, logistical, or environmental barriers in obtaining screening services that accompany food insecurity.

scholarly journals The Network of Angiotensin Receptors in Breast Cancer

Cells ◽  
2020 ◽  
Vol 9 (6) ◽  
pp. 1336
Author(s):  
Filippo Acconcia
Keyword(s):  
Breast Cancer ◽  
Angiotensin Ii ◽  
Current Knowledge ◽  
Molecular System ◽  
Endocrine System ◽  
Renin Angiotensin System ◽  
Angiotensin Receptors ◽  
Transmembrane Receptors ◽  
System Physiology ◽  
Breast Breast Cancer

The renin-angiotensin system (RAS) is a network of proteins regulating many aspects of human physiology, including cardiovascular, pulmonary, and immune system physiology. The RAS is a complicated network of G-protein coupled receptors (GPCRs) (i.e., AT1R, AT2R, MASR, and MRGD) orchestrating the effects of several hormones (i.e., angiotensin II, angiotensin (1–7), and alamandine) produced by protease-based transmembrane receptors (ACE1 and ACE2). Two signaling axes have been identified in the RAS endocrine system that mediate the proliferative actions of angiotensin II (i.e., the AT1R-based pathway) or the anti-proliferative effects of RAS hormones (i.e., the AT2R-, MAS-, and MRGD-based pathways). Disruption of the balance between these two axes can cause different diseases (e.g., cardiovascular pathologies and the severe acute respiratory syndrome coronavirus 2- (SARS-CoV-2)-based COVID-19 disease). It is now accepted that all the components of the RAS endocrine system are expressed in cancer, including cancer of the breast. Breast cancer (BC) is a multifactorial pathology for which there is a continuous need to identify novel drugs. Here, I reviewed the possible roles of both axes of the RAS endocrine network as potential druggable pathways in BC. Remarkably, the analysis of the current knowledge of the different GPCRs of the RAS molecular system not only confirms that AT1R could be considered a drug target and that its inhibition by losartan and candesartan could be useful in the treatment of BC, but also identifies Mas-related GPCR member D (MRGD) as a druggable protein. Overall, the RAS of GPCRs offers multifaceted opportunities for the development of additional compounds for the treatment of BC.

scholarly journals The “Empowering Latinas to Obtain Breast Cancer Screenings” study: Rationale and design

2018 ◽  
Vol 71 ◽  
pp. 1-8 ◽  
Author(s):  
Yamile Molina ◽  
Liliana G. San Miguel ◽  
Lizeth Tamayo ◽  
Casandra Robledo ◽  
Carola Sánchez Díaz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Screenings

scholarly journals Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters

2020 ◽  
pp. 657-665 ◽  
Author(s):  
Jack W. London ◽  
Elnara Fazio-Eynullayeva ◽  
Matvey B. Palchuk ◽  
Peter Sankey ◽  
Christopher McNair
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
Research Network ◽  
Malignant Neoplasms ◽  
Patients With Cancer ◽  
Hematologic Cancer ◽  
Cancer Screenings ◽  
Number Of Patients ◽  
Cancer Types ◽  
The Impact

PURPOSE While there are studies under way to characterize the direct effects of the COVID-19 pandemic on the care of patients with cancer, there have been few quantitative reports of the impact that efforts to control the pandemic have had on the normal course of cancer diagnosis and treatment encounters. METHODS We used the TriNetX platform to analyze 20 health care institutions that have relevant, up-to-date encounter data. Using this COVID and Cancer Research Network (CCRN), we compared cancer cohorts identified by querying encounter data pre-COVID (January 2019-April 2019) and current (January 2020-April 2020). Cohorts were generated for all patients with neoplasms (malignant, benign, in situ, and of unspecified behavior), with new incidence neoplasms (first encounter), with exclusively malignant neoplasms, and with new incidence malignant neoplasms. Data from a UK institution were similarly analyzed. Additional analyses were performed on patients with selected cancers, as well as on those having had cancer screening. RESULTS Clear trends were identified that suggest a significant decline in all current cohorts explored, with April 2020 displaying the largest decrease in the number of patients with cancer having encounters. Of the cancer types analyzed, lung, colorectal, and hematologic cancer cohorts exhibited smaller decreases in size in April 2020 versus 2019 (−39.1%, −39.9%, −39.1%, respectively) compared with cohort size decreases for breast cancer, prostate cancer, and melanoma (−47.7%, −49.1%, −51.8%, respectively). In addition, cancer screenings declined drastically, with breast cancer screenings dropping by −89.2% and colorectal cancer screenings by −84.5%. CONCLUSION Trends seen in the CCRN clearly suggest a significant decrease in all cancer-related patient encounters as a result of the pandemic. The steep decreases in cancer screening and patients with a new incidence of cancer suggest the possibility of a future increase in patients with later-stage cancer being seen initially as well as an increased demand for cancer screening procedures as delayed tests are rescheduled.

Sign in / Sign up

Export Citation Format

Share Document